Zacks Research Weighs in on Prestige Consumer Healthcare Inc.'s Q3 2026 Earnings (NYSE:PBH)

Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) - Investment analysts at Zacks Research lifted their Q3 2026 earnings estimates for Prestige Consumer Healthcare in a research report issued to clients and investors on Thursday, May 2nd. Zacks Research analyst R. Department now expects that the company will post earnings per share of $1.20 for the quarter, up from their prior estimate of $1.19. The consensus estimate for Prestige Consumer Healthcare's current full-year earnings is $4.33 per share. Zacks Research also issued estimates for Prestige Consumer Healthcare's FY2026 earnings at $4.76 EPS.

Several other equities analysts also recently weighed in on PBH. TheStreet raised shares of Prestige Consumer Healthcare from a "c+" rating to a "b-" rating in a report on Monday, February 12th. StockNews.com raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, February 10th. One investment analyst has rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, Prestige Consumer Healthcare has an average rating of "Moderate Buy" and a consensus target price of $110.00.

Prestige Consumer Healthcare Price Performance

NYSE:PBH traded up $0.02 during trading hours on Monday, hitting $70.02. 190,274 shares of the stock traded hands, compared to its average volume of 234,840. The company has a quick ratio of 1.92, a current ratio of 3.09 and a debt-to-equity ratio of 0.75. Prestige Consumer Healthcare has a 1 year low of $55.96 and a 1 year high of $75.31. The company has a market cap of $3.48 billion, a price-to-earnings ratio of -42.69, a price-to-earnings-growth ratio of 1.90 and a beta of 0.53. The stock has a 50 day moving average price of $71.12 and a 200 day moving average price of $64.73.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings data on Thursday, February 8th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.04 by $0.02. Prestige Consumer Healthcare had a negative net margin of 7.11% and a positive return on equity of 14.09%. The company had revenue of $282.74 million for the quarter, compared to the consensus estimate of $280.25 million. During the same quarter last year, the firm posted $1.04 earnings per share. The firm's revenue was up 2.6% compared to the same quarter last year.

Insider Buying and Selling

In related news, SVP Mary Beth Fritz sold 5,336 shares of the business's stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $69.00, for a total value of $368,184.00. Following the sale, the senior vice president now owns 15,934 shares in the company, valued at $1,099,446. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.60% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of PBH. Ariel Investments LLC grew its holdings in shares of Prestige Consumer Healthcare by 173.8% in the third quarter. Ariel Investments LLC now owns 2,534,786 shares of the company's stock worth $144,964,000 after purchasing an additional 1,609,044 shares during the last quarter. Congress Asset Management Co. MA lifted its stake in Prestige Consumer Healthcare by 596.2% in the fourth quarter. Congress Asset Management Co. MA now owns 679,256 shares of the company's stock worth $41,584,000 after acquiring an additional 581,685 shares during the period. Norges Bank purchased a new stake in Prestige Consumer Healthcare in the fourth quarter worth about $27,739,000. Allspring Global Investments Holdings LLC lifted its stake in Prestige Consumer Healthcare by 19.1% in the third quarter. Allspring Global Investments Holdings LLC now owns 1,087,821 shares of the company's stock worth $62,213,000 after acquiring an additional 174,416 shares during the period. Finally, Norden Group LLC lifted its stake in Prestige Consumer Healthcare by 1,593.7% in the first quarter. Norden Group LLC now owns 118,968 shares of the company's stock worth $8,632,000 after acquiring an additional 111,944 shares during the period. Institutional investors own 99.95% of the company's stock.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.